Health and Employment After Gastro Intestinal Surgery - HEAGIS1

Sponsor
University of Padova (Other)
Overall Status
Completed
CT.gov ID
NCT04466592
Collaborator
Humanitas Hospital, Italy (Other), Istituto Oncologico Veneto IRCCS (Other)
47
2
1
16.6
23.5
1.4

Study Details

Study Description

Brief Summary

By using the M.A.D.I.T. methodology and the Dialogics science, SALVO Project aims to develop operational guidelines to support oncological target patients in the resumption of their daily post-operative activities. The research will implement an instrument for the purpose of measuring the health need of participants who are admitted to the surgical ward. Therefore, targeted interventions will be implemented with participants, and efficacy will be evaluated in order to define treatment guidelines.

The principal aim of this study is to create a validated and replicable intervention model for supporting patients who undergone surgery for esophagus and gastro intestinal cancer.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Promotion of competences of participant involved in the management of the post operative period
N/A

Detailed Description

Several studies highlight how patients diagnosed with a digestive tract cancer, experience difficulties in returning to work after treatment, leading to socio-economic spill-over effects.

A specific 16 questions questionnaire had been developed for this study, the "Health and Employment After Gastro Intestinal Surgery Dialogical Questionnaire" (HEADS-DQ). It investigate peculiar patient competences involved after surgery: future forethought; context evaluation; consequences of own actions forethought; use of available resources, each relevant to four areas: clinical; familiar; working; daily-activities.

Through this questionnaire patient ability in dealing with after surgery consequences will be evaluated in order to define targeted support, which will be offered by professional psychologists. These interventions efficacy will be evaluated through another administration of the HEADS-DQ.

Study Design

Study Type:
Interventional
Actual Enrollment :
47 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Participants will receive the supportive intervention based on the results of the HEADS-DQ during the post operative period.Participants will receive the supportive intervention based on the results of the HEADS-DQ during the post operative period.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
SAlute e LaVoro in Chirurgia Oncologica (SALVO)
Actual Study Start Date :
Dec 13, 2019
Actual Primary Completion Date :
Feb 28, 2021
Actual Study Completion Date :
Apr 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Supportive intervention

A research psychologist will support participants, promoting their competences in the recover of work and social activities, such as the compliance.

Behavioral: Promotion of competences of participant involved in the management of the post operative period
The research psychologist will be in touch with the participants for 9 months after the surgery (weekly, biweekly or monthly) in order to help them recovering social and work activities, and dealing with the consequences of the surgery. Specifically, four competences will be promoted (future forethought; context evaluation; consequences of own actions forethought; use of available resources), each relevant to four areas (clinical; familiar; working; daily-activities).

Outcome Measures

Primary Outcome Measures

  1. participants' health competences [9 months after the surgery]

    competences measured by HEAGIS-DQ. competences measured by HEAGIS-DQ (Health and Employment After Gastro intestinal Surgery - Dialogical Questionnaire): the questionnaire gives an evaluation of the four competences (future forethought; context evaluation; consequences of own actions forethought; use of available resources), for each of the four areas(clinical; familiar; working; daily-activities). Each competence can be "low", "medium" or "high". Best level: "high level"

  2. anxiety and depression [9 months after the surgery]

    HADS - Hospital Anxiety and Depression Scale measures. score range for depression: 0 - 7 Normal / 8 - 10 borderline / 11 - 17 Abnormal score range for Anxiety: 0 - 7 Normal / 8 - 10 borderline / 11 - 17 Abnormal

  3. general quality of life [9 months after the surgery]

    measured by EORTC QLQ C30 (European Organisation for Research and Treatment of Cancer - Quality of Life of Cancer patients) Role, social, emotional scales: range score for functional scale: 0 (worst) - 100 (best) Financial difficulties: range score for symptoms scale: 0 (best) - 100 (worst) Global health status: range score for global health: 0 (worst) - 100 (best)

Secondary Outcome Measures

  1. Number of participants maintaining their job [9 months after the surgery]

  2. Number of participants with jejunostomy maintaining their job [9 months after the surgery]

  3. Number of participants maintaining their social activities [9 months after the surgery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years old;

  • Comprehension of Italian language;

  • Esophageal or gastro intestinal cancer diagnosis;

  • Curative surgery for neoplasm;

  • No metastasis;

Exclusion Criteria:
  • <18 years old

  • Non comprehension of Italian language;

  • No esophageal or gastro intestinal cancer diagnosis;

  • Palliative ;

  • Cancer recurrence or metastasis.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Humanitas Mirasole S.p.a. Rozzano Milan Italy 20089
2 Istituto Oncologico Veneto - IOV IRCSS Castelfranco Veneto Treviso Italy 31033

Sponsors and Collaborators

  • University of Padova
  • Humanitas Hospital, Italy
  • Istituto Oncologico Veneto IRCCS

Investigators

  • Principal Investigator: Gian Piero Turchi, University of Padova

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Padova
ClinicalTrials.gov Identifier:
NCT04466592
Other Study ID Numbers:
  • 232050
First Posted:
Jul 10, 2020
Last Update Posted:
Jan 14, 2022
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Padova
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 14, 2022